Articles with public access mandates - Raffi Tachdjian, MD, MPHLearn more
Available somewhere: 4
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: a randomized, double-blind, placebo-controlled phase 3 trial
B Zuraw, WR Lumry, DT Johnston, E Aygören-Pürsün, A Banerji, ...
Journal of Allergy and Clinical Immunology 148 (1), 164-172. e9, 2021
Mandates: US National Institutes of Health
Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma
R Tachdjian, C Mathias, S Al Khatib, PJ Bryce, HS Kim, F Blaeser, ...
Journal of Experimental Medicine 206 (10), 2191-2204, 2009
Mandates: US National Institutes of Health
In vivo regulation of the allergic response by the IL-4 receptor α chain immunoreceptor tyrosine-based inhibitory motif
R Tachdjian, S Al Khatib, A Schwinglshackl, HS Kim, A Chen, J Blasioli, ...
Journal of Allergy and Clinical Immunology 125 (5), 1128-1136. e8, 2010
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age
FI Hsu, W Lumry, M Riedl, R Tachdjian
Allergy, Asthma & Clinical Immunology 18 (1), 64, 2022
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program